Literature DB >> 7908122

The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex.

E Schlicker1, M Kathmann, H J Exner, M Detzner, M Göthert.   

Abstract

We analyzed the facilitatory effect of the 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide (mCPBG) on the electrically evoked noradrenaline release in superfused mouse brain tissue. In addition, we determined the affinities of mCPBG and two other 5-HT receptor ligands, namely 2-methyl-5-hydroxytryptamine (2-methyl-5-HT; also a 5-HT3 receptor agonist) and 5-carboxamidotryptamine (5-CT; a 5-HT1 receptor agonist) for alpha 2 binding sites. The latter two 5-HT receptor agonists were included because of the claimed involvement of alpha 2-adrenoceptors in their effects on noradrenaline release. In superfusion experiments on mouse brain cortex slices preincubated with 3H-noradrenaline, tritium overflow evoked by 2-min periods of electrical field stimulation (3 Hz) was facilitated by mCPBG and, in addition, by rauwolscine (alpha 2-adrenoceptor antagonist) and tetraethylammonium (K+ channel blocker) (which were examined for comparison). The effect of mCPBG was not affected by the 5-HT3 receptor antagonist tropisetron or by desipramine but was abolished by rauwolscine. In slices superfused with medium containing desipramine, the concentration-response curve of unlabelled noradrenaline for its inhibitory effect on the electrically (0.3 Hz) evoked overflow was shifted to the right by mCPBG and rauwolscine (apparent pA2 5.35 and 7.88, respectively). In another series of superfusion experiments, 4 electrical pulses, administered at 100 Hz, were used to evoke tritium overflow. Tritium overflow evoked by this stimulation procedure (under which an endogenous tone of noradrenaline does not develop) was not affected by mCPBG and rauwolscine but still increased by tetraethylammonium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908122     DOI: 10.1007/bf00178201

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Mutual interaction of histamine H3-receptors and alpha 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex.

Authors:  E Schlicker; A Behling; G Lümmen; B Malinowska; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

Review 2.  5-HT3 receptors.

Authors:  G J Kilpatrick; K T Bunce; M B Tyers
Journal:  Med Res Rev       Date:  1990 Oct-Dec       Impact factor: 12.944

Review 3.  Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors.

Authors:  D Hoyer
Journal:  Neuropsychopharmacology       Date:  1990 Oct-Dec       Impact factor: 7.853

Review 4.  The pharmacology of potassium channels and their therapeutic potential.

Authors:  N S Cook
Journal:  Trends Pharmacol Sci       Date:  1988-01       Impact factor: 14.819

5.  Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program.

Authors:  G A McPherson; P Molenaar; C Raper; E Malta
Journal:  J Pharmacol Methods       Date:  1983-12

Review 6.  Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms.

Authors:  E A Singer
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

7.  Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors.

Authors:  E Schlicker; K Fink; M Hinterthaner; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

8.  1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

Authors:  G J Kilpatrick; A Butler; J Burridge; A W Oxford
Journal:  Eur J Pharmacol       Date:  1990-06-21       Impact factor: 4.432

9.  5-HT3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex.

Authors:  R M Johnson; G T Inouye; R M Eglen; E H Wong
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

10.  Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers.

Authors:  L Hedler; G Stamm; R Weitzell; K Starke
Journal:  Eur J Pharmacol       Date:  1981-03-05       Impact factor: 4.432

View more
  5 in total

1.  Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat.

Authors:  S M Garraway; S Hochman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor.

Authors:  Kirsten Schulte; Nina Steingrüber; Bernd Jergas; Agnes Redmer; Christina Maria Kurz; Rainer Buchalla; Beat Lutz; Andreas Zimmer; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-04       Impact factor: 3.000

3.  Effects of iodoproxyfan, a potent and selective histamine H3 receptor antagonist, on alpha 2 and 5-HT3 receptors.

Authors:  E Schlicker; H Pertz; H Bitschnau; K Purand; M Kathmann; S Elz; W Schunack
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

4.  Effects of 5-HT receptor agonists on depolarization-induced [3H]-noradrenaline release in rabbit hippocampus and human neocortex.

Authors:  C Allgaier; P Warnke; A P Stangl; T J Feuerstein
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Urethane, but not pentobarbitone, attenuates presynaptic receptor function in rats: a contribution to the choice of anaesthetic.

Authors:  Cm Kurz; U Baranowska; S Lupiński; M Göthert; B Malinowska; E Schlicker
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.